Keywords
Last Name
Institution

STEPHEN Z FADEM

TitleClinical Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
DivisionMedicine-Nephrology
Address6655 Travis, Suite 720
Houston TX 77030
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Yagil Y, Fadem SZ, Kant KS, Bhatt U, Sika M, Lewis JB, Negoi D. Managing hyperphosphatemia in patients with chronic kidney disease on dialysis with ferric citrate: latest evidence and clinical usefulness. Ther Adv Chronic Dis. 2015 Sep; 6(5):252-63. PMID: 26336594.
      View in: PubMed
    2. Van Buren PN, Lewis JB, Dwyer JP, Greene T, Middleton J, Sika M, Umanath K, Abraham JD, Arfeen SS, Bowline IG, Chernin G, Fadem SZ, Goral S, Koury M, Sinsakul MV, Weiner DE. The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial. Am J Kidney Dis. 2015 Sep; 66(3):479-88. PMID: 25958079.
      View in: PubMed
    3. Friedman AN, Fadem SZ. A more cautious stance on nutritional supplementation for hypoalbuminemia is justified. Am J Kidney Dis. 2013 Feb; 61(2):349. PMID: 23318014.
      View in: PubMed
    4. Ozar DT, Kristensen C, Fadem SZ, Blaser R, Singer D, Moss AH. Nephrologists' professional ethics in dialysis practices. Clin J Am Soc Nephrol. 2013 May; 8(5):840-4. PMID: 23220423.
      View in: PubMed
    5. Friedman AN, Fadem SZ. Making measures count. Clin J Am Soc Nephrol. 2011 Jun; 6(6):1507-11. PMID: 21597026.
      View in: PubMed
    6. Fadem SZ, Walker DR, Abbott G, Friedman AL, Goldman R, Sexton S, Buettner K, Robinson K, Peters TG. Satisfaction with renal replacement therapy and education: the American Association of Kidney Patients survey. Clin J Am Soc Nephrol. 2011 Mar; 6(3):605-12. PMID: 21330485; PMCID: PMC3082420.
    7. Mermel LA, Eells SJ, Acharya MK, Cartony JM, Dacus D, Fadem S, Gay EA, Gordon S, Lonks JR, Perl TM, McDougal LK, McGowan JE, Maxey G, Morse D, Tenover FC. Quantitative analysis and molecular fingerprinting of methicillin-resistant Staphylococcus aureus nasal colonization in different patient populations: a prospective, multicenter study. Infect Control Hosp Epidemiol. 2010 Jun; 31(6):592-7. PMID: 20402589.
      View in: PubMed
    8. Friedman AN, Fadem SZ. Reassessment of albumin as a nutritional marker in kidney disease. J Am Soc Nephrol. 2010 Feb; 21(2):223-30. PMID: 20075063.
      View in: PubMed
    9. Fadem SZ, Al-Saghir F, Zollner G, Swan S. Converting hemodialysis patients from intravenous paricalcitol to intravenous doxercalciferol - a dose equivalency and titration study. Clin Nephrol. 2008 Oct; 70(4):319-24. PMID: 18826857.
      View in: PubMed
    10. Wintz R, Rosenthal B, Fadem SZ. The Physician Quality Reporting Initiative: a practical approach to implementing quality reporting. Adv Chronic Kidney Dis. 2008 Jan; 15(1):56-63. PMID: 18155110.
      View in: PubMed
    11. Buettner K, Fadem SZ. The internet as a tool for the renal community. Adv Chronic Kidney Dis. 2008 Jan; 15(1):73-82. PMID: 18155112.
      View in: PubMed
    12. Fadem SZ, Moe SM. Management of chronic kidney disease mineral-bone disorder. Adv Chronic Kidney Dis. 2007 Jan; 14(1):44-53. PMID: 17200043.
      View in: PubMed
    13. Fadem SZ, Moe SM. Management of chronic kidney disease-mineral bone disorder. Adv Chronic Kidney Dis. 2007 Jan; 14(1):2. PMID: 17200037.
      View in: PubMed
    14. Coyne D, Acharya M, Qiu P, Abboud H, Batlle D, Rosansky S, Fadem S, Levine B, Williams L, Andress DL, Sprague SM. Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD. Am J Kidney Dis. 2006 Feb; 47(2):263-76. PMID: 16431255.
      View in: PubMed
    15. Fadem S. The need for computer-based patient education. Adv Chronic Kidney Dis. 2005 Jul; 12(3):335-8. PMID: 16010648.
      View in: PubMed
    16. Spergel LM, Holland JE, Fadem SZ, McAllister CJ, Peacock EJ. Static intra-access pressure ratio does not correlate with access blood flow. Kidney Int. 2004 Oct; 66(4):1512-6. PMID: 15458445.
      View in: PubMed
    17. Michael B, Coyne DW, Fishbane S, Folkert V, Lynn R, Nissenson AR, Agarwal R, Eschbach JW, Fadem SZ, Trout JR, Strobos J, Warnock DG. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran. Kidney Int. 2002 May; 61(5):1830-9. PMID: 11967034.
      View in: PubMed
    18. Fadem SZ. Helping patients, renal staff gain access to information. Nephrol News Issues. 1998 Apr; 12(4):38-9. PMID: 9601369.
      View in: PubMed
    19. Rosenblatt SG, Drake S, Fadem S, Welch R, Lifschitz MD. Gastrointestinal blood loss in patients with chronic renal failure. Am J Kidney Dis. 1982 Jan; 1(4):232-6. PMID: 6984289.
      View in: PubMed
    20. Patak RV, Fadem SZ, Lifschitz MD, Stein JH. Study of factors which modify the development of norepinephrine-induced acute renal failure in the dog. Kidney Int. 1979 Mar; 15(3):227-37. PMID: 513486.
      View in: PubMed
    21. Fadem SZ, Lifschitz MD. Use of saralasin in end-stage renal disease. Kidney Int Suppl. 1979 Mar; (9):S93-100. PMID: 289869.
      View in: PubMed
    22. Mauk RH, Patak RV, Fadem SZ, Lifschitz MD, Stein JH. Effect of prostaglandin E administration in a nephrotoxic and a vasoconstrictor model of acute renal failure. Kidney Int. 1977 Aug; 12(2):122-30. PMID: 916501.
      View in: PubMed
    FADEM's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _